TIPE1 Suppresses Growth and Metastasis of Ovarian Cancer

Zhenyu Zhang1, Minghui Chang1, Xingguo Song1

  • 1Department of Clinical Laboratory, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China.

Journal of Oncology
|June 30, 2021
PubMed

Insights

Tumor necrosis factor alpha-induced protein 8-like protein 1 (TIPE1) suppresses ovarian cancer growth and metastasis. This protein is downregulated in ovarian cancer, suggesting TIPE1 as a potential therapeutic target and metastasis predictor.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • The TNFAIP8-like (TIPE) protein family, including TIPE1, is implicated in tumorigenesis and immune regulation.
  • The specific role of TIPE1 in ovarian cancer, particularly concerning tumor metastasis, is not well understood.

Purpose of the Study:

  • To investigate the protein expression profile of TIPE1 in normal human tissues.
  • To explore the relationship between TIPE1 expression and metastasis in ovarian cancer.
  • To elucidate the functional role of TIPE1 in ovarian cancer progression.

Main Methods:

  • Immunohistochemistry (IHC) staining was employed to determine TIPE1 protein expression in various normal human tissues and ovarian cancer tissues.
  • In vitro assays were conducted to assess the effects of TIPE1 on ovarian cancer cell growth, colony formation, and migration.
  • In vivo studies were performed to evaluate the impact of TIPE1 on ovarian cancer tumorigenesis and metastasis.
  • Epithelial-mesenchymal transition (EMT) markers were analyzed to understand the mechanism of TIPE1's action.

Main Results:

  • TIPE1 protein exhibits a distinct expression pattern in normal human tissues, found in the cytoplasm and sometimes the nucleus of specific epithelial cells.
  • TIPE1 protein is significantly downregulated in ovarian cancer tissues compared to adjacent non-cancerous tissues.
  • TIPE1 suppresses ovarian cancer cell growth, colony formation, migration, and epithelial-mesenchymal transition (EMT) both in vitro and in vivo.
  • Evidence indicates TIPE1 inhibits tumor metastasis in ovarian cancer models.

Conclusions:

  • TIPE1 acts as a suppressor of ovarian cancer metastasis.
  • Downregulation of TIPE1 in ovarian cancer suggests its potential as a biomarker for metastasis.
  • TIPE1 represents a promising novel therapeutic target for managing ovarian cancer progression and metastasis.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.3K